AmSurg Corp. 1,500,000 Shares Mandatory Convertible Preferred Stock, Series A-1 (no par value) Underwriting AgreementAmsurg Corp • July 2nd, 2014 • Services-offices & clinics of doctors of medicine • New York
Company FiledJuly 2nd, 2014 Industry JurisdictionAmSurg Corp., a corporation organized under the laws of Tennessee (the “Company”), proposes to sell to the several underwriters named in Schedule II hereto (the “Underwriters”), for whom you (the “Representatives”) are acting as representatives, the number of shares of mandatory convertible preferred stock, Series A-1, no par value (“Series A-1 Preferred Stock”), of the Company set forth in Schedule I hereto (the “Securities”) (said shares to be issued and sold by the Company being hereinafter called the “Firm Securities”). The Company also proposes to grant to the Underwriters an option to purchase up to the number of additional shares of Series A-1 Preferred Stock set forth in Schedule I hereto (the “Option Securities”; the Option Securities, together with the Firm Securities, being hereinafter called the “Securities”). The Series A-1 Preferred Stock will be convertible into shares of the Company’s common stock (“Common Stock”), no par value, at a variable conversion rate set forth i
AmSurg Corp. 8,500,000 Shares Common Stock (no par value) Underwriting AgreementAmsurg Corp • July 2nd, 2014 • Services-offices & clinics of doctors of medicine • New York
Company FiledJuly 2nd, 2014 Industry JurisdictionAmSurg Corp., a corporation organized under the laws of Tennessee (the “Company”), proposes to sell to the several underwriters named in Schedule II hereto (the “Underwriters”), for whom you (the “Representatives”) are acting as representatives, the number of shares of common stock, no par value (“Common Stock”), of the Company set forth in Schedule I hereto (the “Securities”) (said shares to be issued and sold by the Company being hereinafter called the “Firm Securities”). The Company also proposes to grant to the Underwriters an option to purchase up to the number of additional shares of Common Stock set forth in Schedule I hereto (the “Option Securities”; the Option Securities, together with the Firm Securities, being hereinafter called the “Securities”). To the extent there are no additional Underwriters listed on Schedule I other than you, the term Representatives as used herein shall mean you, as Underwriters, and the terms Representatives and Underwriters shall mean either the s